![Elias Bjornson](https://www.triglycerideforum.org/wp-content/uploads/2023/09/EBjornson-150x150.jpg)
Keynote – On the atherogenicity of remnant particles: Novel genetic insights
Dr Elias BjörnsonWatch the presentation >
![Karin Bornfeldt](https://www.triglycerideforum.org/wp-content/uploads/2022/04/Karin-Bornfeldt-150x150.png)
Insights into apoC3’s mechanism of action
Karin BornfeldtWatch the presentation >
![Steven Grinspoon](https://www.triglycerideforum.org/wp-content/uploads/2023/09/SGrinspoon-150x150.png)
CVD risk reduction in HIV infection: The REPRIEVE Trial
Steven GrinspoonWatch the presentation >
![Magnus Back](https://www.triglycerideforum.org/wp-content/uploads/2023/09/back-150x150.jpg)
CVD and omega-3 fatty acids: Is arterial inflammation the key?
Professor Magnus BäckWatch the presentation >
![David Hare](https://www.triglycerideforum.org/wp-content/uploads/2023/09/DHare-150x150.jpg)
What is your choice of therapeutic target for TG lowering? The cardiologist’s viewpoint
Professor David HareWatch the presentation >
![Klaus Parhofer](https://www.triglycerideforum.org/wp-content/uploads/2021/09/Parhofer-1-edited-150x150.jpg)
What is your choice of therapeutic target for TG lowering? The endocrinologist’s viewpoint
Professor Klaus ParhoferWatch the presentation >
Educational partners and supporters
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
![Arrowhead Pharmaceuticals](https://www.triglycerideforum.org/wp-content/uploads/2023/10/arrowhead_logo.png)
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
![Ionis Logo](https://www.triglycerideforum.org/wp-content/uploads/2021/08/IonisLogo.png)
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
![Kowa Logo](https://www.triglycerideforum.org/wp-content/uploads/2020/11/kowaEnglish_mark.jpg)